ClinConnect ClinConnect Logo
Search / Trial NCT00977366

Neurophysiology of Cough Reflex Hypersensitivity

Launched by UNIVERSITY OF MANCHESTER · Sep 14, 2009

Trial Information

Current as of April 30, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy volunteers inclusion:
  • Over 18 years
  • Measurable cough reflex sensitivity - required as is the primary end-point
  • No current or past history of chronic cough or chronic respiratory disease
  • Chronic Cough Patients inclusion:
  • Over 18 years
  • Chronic persistent cough (\> 8 weeks) despite investigation and/or treatment trials for cough variant asthma/post-nasal drip and gastro-oesophageal reflux
  • Normal chest radiograph - primary respiratory cause for cough excluded
  • Normal lung function - primary respiratory cause for cough excluded Measurable cough reflex sensitivity - required as primary end-point
  • Exclusion Criteria:
  • Recent upper respiratory tract infection (\<4 weeks) - this can lead to increased sensitivity of the cough reflex which resolves as the infection settles
  • Pregnancy/breast-feeding - unknown effects of oesophageal acid infusion
  • Current smokers or ex-smokers with \< 6 month abstinence or history \> 20 pack years - smoking can alter the sensitivity of the cough reflex
  • Opiate or ACE inhibitor use or centrally acting medication - can alter the cough reflex sensitivity
  • Symptomatic gastro-oesophageal reflux, post-nasal drip or asthma (chronic cough cohort may have been treated for these in the past but cough did not resolve) - these conditions are known to cause cough and alter cough reflex sensitivity
  • Significant ongoing chronic respiratory/cardiovascular/gastro-intestinal/haematological/ neurological/psychiatric illness. We are aiming to recruit healthy volunteers and chronic cough patients who are otherwise healthy

About University Of Manchester

The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.

Locations

Manchester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Ashley Woodcock, Prof

Principal Investigator

The University of Manchester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials